Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Lansdowne Partners European Fund 2024 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (Lansdowne Partners European Fund)

Primary Source Intelligence • Q1 2024 Letter Analysis

Lansdowne Partners European Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Lansdowne Partners European Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD+6.99%

YTD+6.99%

Annualized+10.13%

Positioning StanceConstructive

Market CapLarge Cap

GeographyEurope

Digest Analysis

Quick Take

"Key moves included initiating ASML on semiconductor strength, adding to undervalued KBC ahead of rate cuts, and opening EssilorLuxottica on integration completion."

Executive Summary

Lansdowne European Fund returned 6.99% in Q1 2024, slightly underperforming the MSCI Europe benchmark's 7.63%. The fund maintains a concentrated approach with 20-30 holdings across European mid to large cap companies. Key additions included building a starter position in ASML, leveraging its monopolistic position in EUV lithography equipment and strong bookings momentum. The team added to KBC as regulatory headwinds subside and ECB rate cuts approach, viewing the bank as substantially underpriced at 9x earnings. New position EssilorLuxottica capitalizes on the completed integration and dominant position in the growing eye-care industry. Defense spending emerged as a key theme with Leonardo positioned to benefit from the expected European defense up-cycle driven by geopolitical tensions. The managers reduced positions in Iberdrola, Nestle, and Sika, citing limited growth prospects, execution concerns, and weak end markets respectively. The portfolio reflects selective positioning across technology, defense, financials, and healthcare sectors, with emphasis on companies benefiting from secular growth drivers including AI integration and demographic trends.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

Moderate-high conviction evidenced by concentrated 20-30 position portfolio with detailed thesis explanations for each holding. Specific position sizing language ('added to our holding', 'build a starter position', 'reduce our position') and clear catalysts demonstrate conviction, though hedged language like 'could look to increase' prevents higher scoring.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The manager shows mild positive sentiment with selective opportunities identified across sectors. While acknowledging some market challenges like construction weakness, they express confidence in specific secular trends like defense spending and AI integration.

Risk Appetite

15%

DefensiveAggressive

Defensive (15%)

Portfolio positioning shows selective risk appetite with new positions opened (ASML, EssilorLuxottica) and existing holdings increased (KBC), balanced by reductions in other names. The approach is measured rather than aggressive.

Capital Deployment

15%

De-riskingDeploying

De-risking (15%)

Modest net deployment with new positions opened (ASML, EssilorLuxottica) and additions to KBC, offset by reductions in Iberdrola, Nestle, and Sika. The activity suggests selective rotation rather than aggressive deployment, with cash remaining low at 0.5%.

Forward Guidance

10%

CautiousExpansionary

Cautious (10%)

Forward guidance is cautiously optimistic with language like 'could look to increase our position over time as we increase our conviction levels' and 'awaiting a better entry point' suggesting selective deployment bias.

Language Signal

20%

BearishBullish

Bearish (20%)

Language balance leans slightly positive with terms like 'attractive', 'underpriced', 'well positioned', and 'supportive outlook' outweighing risk language, though concerns about end market weakness and execution are noted.

Perceived Risk

35%

Low RiskElevated

Moderate Risk (35%)

Moderate risk acknowledgment with specific concerns identified including construction market weakness, weight loss drug impacts on food companies, and regulatory pressures on banks. Risks are named and discussed but not central to the letter's narrative.

Opportunity Density

60%

ScarceAbundant

Selective (60%)

Selective opportunities identified in defined areas including semiconductor equipment, European banking, defense, and eye-care. Manager sees specific attractive names but emphasizes selectivity and monitoring for better entry points, suggesting moderate opportunity density.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

Multi-year investment horizon evidenced by discussion of secular trends like defense spending up-cycle 'in the coming decade' and structural growth drivers. Language around monitoring positions 'over time' and waiting for 'better entry points' suggests patient capital approach typical of 2-5 year investment horizons.